1
2
3
4
5
6
2
3
4
5
6
Published In
Archives of Rheumatology
Volume: 35 Issue: 3, September 2020
Pages: 366-375
History
Published Online: September 30, 2020
This work is licensed under a Creative Commons Attribution 4.0 International License.
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Abstract
Objectives: This study aims to assess the efficacy and safety of mycophenolate mofetil (MMF) on lung function and skin thickness in Korean patients with systemic sclerosis-interstitial lung disease (SSc-ILD) in a real-world setting.
Patients and methods: This retrospective, medical chart-based study was performed at four centers in South Korea and included 34 patients (2 males, 32 females; median age 50.5 years; range, 25 to 72 years) with SSc-ILD. We investigated changes in forced vital capacity (FVC), diffusion capacity of the lung for carbon monoxide (DLCO), and modified Rodnan skin score (mRSS) according to MMF treatment for 24 months.
Results: The mean dose and treatment duration of MMF were 1,338.2±439.0 mg/day and 13.1±9.3 months, respectively. Although FVC decreased significantly at 15 months, FVC and DLCO did not change significantly during treatment with MMF. Median mRSS decreased significantly from 17.5 (2-40) to 10.5 (2-40) units (p<0.0001). Thirteen patients (38.24%) discontinued treatment with MMF [treatment duration 8.00 (3.0-24.0) months]; the predominant cause of discontinuation was of economic nature (46.15%). No serious adverse events were reported.
Conclusion: This real-world based study supports the role of MMF in the stabilization of lung function and the improvement in skin thickness with an acceptable safety profile in patients with SSc. Economic burden is the main cause of discontinued treatment with MMF.
Similar Articles
Similar Articles
- Deniz EVCİK, Rehabilitative Approach to Rheumatological Diseases , Archives of Rheumatology: Vol. 27 No. 4 (2012): The Archives of Rheumatology
- Sooin Park, Moon-Ju Kim, Yu Jeong Lee, Sung Min Yu, Hae-in Lee, So-Hee Jin, A-ra Choi, Seung Cheol Shim, Eun Jeong Won, Tae-Jong Kim, A Pilot Study on the Anti-Inflammatory Effects of Tacrolimus in Ankylosing Spondylitis: Evidence from Human Samples and a Murine Model , Archives of Rheumatology: Vol. 40 No. 2 (2025): The Archives of Rheumatology
- Liang-jun XIE, Jian-fang LI, Zhi LIU, Feng ZHANG, Chang ZHAO, Lu-ping QIN, Ting-jie ZHANG, Mu-hua CHENG, Immunoglobulin G4-Related Lung Disease Presenting as Lung Cavitating Mass and Mimicking Lung Cancer , Archives of Rheumatology: Vol. 32 No. 4 (2017): The Archives of Rheumatology
- Jihye Bang, Gyeonghwa Kim, Soo Young Park, Hye Ra Jung, Sang-Hyon Kim, Ji-Min Kim, GCSB-5 regulates inflammatory arthritis and pain by modulating the mitogen-activated protein kinase signaling pathway in a murine model of rheumatoid arthritis , Archives of Rheumatology: Vol. 38 No. 4 (2023): The Archives of Rheumatology
- Cem Zafer Yıldır, Ejder Berk, Vedat Nacitarhan, Burhan Fatih Koçyiğit, Tuba Tülay Koca, Adnan Demirel, Balance Abilities and Kinesiophobia in Women with Fibromyalgia Syndrome: A Cross-Sectional Comparative Study , Archives of Rheumatology: Vol. 40 No. 3 (2025): Archives of Rheumatology
- Duygu GÜMÜŞ, Özge BAŞARAN, Nilgün ÇAKAR, Nermin UNCU, Banu ÇELİKEL ACAR, Evaluation of Childhood Health Assessment Questionnaire in Juvenile Idiopathic Arthritis: A Single Center Experience From Turkey , Archives of Rheumatology: Vol. 30 No. 1 (2015): The Archives of Rheumatology
- Somsak Punjasamanvong, Chayawee Muangchan, Persistent eosinophilia and associated organ involvement in Thai patients with systemic sclerosis: Data from the Siriraj scleroderma cohort , Archives of Rheumatology: Vol. 36 No. 4 (2021): The Archives of Rheumatology
- Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang, Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis , Archives of Rheumatology: Vol. 40 No. 3 (2025): Archives of Rheumatology
- Mahmut ALPAYCI, Colchicine as a Possible Alternative Treatment for Chronic Recurrent Multifocal Osteomyelitis , Archives of Rheumatology: Vol. 28 No. 4 (2013): The Archives of Rheumatology
- Mustafa ÇAKAN, Nuray AKTAY AYAZ, Funda EROL ÇİPE, Şerife GÜL KARADAĞ, Immunodeficiency-Like Phenotype, Recurrent Pulmonary Manifestations, and Persistent Polyarthritis: Mevalonate Kinase Deficiency Successfully Treated With Adalimumab , Archives of Rheumatology: Vol. 35 No. 4 (2020): The Archives of Rheumatology
<< < 2 3 4 5 6 7 8 9 10 11 > >>
You may also start an advanced similarity search for this article.
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Vol. 35 No. 3 (2020): The Archives of Rheumatology
Pages
366-375
History
Published Online
September 30, 2020
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
2
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
3
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
4
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
5
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
6
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Cite this Article
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Outlines